Clinical Trial

Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus

Name: Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus — clinical trial record (NCT06691152)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SLE

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is an investigator-initiated trial to evaluate the safety and efficacy of CD19 Universal CAR-T cells in the treatment of refractory systemic lupus erythematosus.

Trial Details

NCT Number	NCT06691152
Lead Sponsor	The Children's Hospital of Zhejiang University School of Medicine
Conditions	Systemic Lupus Erythematosus
Enrollment	18 participants
Start Date	2024-10-30
Primary Completion	2027-09-30 (estimated)
Study Completion	2027-09-30 (estimated)
Updated on ClinicalTrials.gov	2024-11-15